“Inflammasomes as a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature” (2023) Principles and Practice of Clinical Research, 9(2). doi:10.21801/ppcrj.2023.92.7.